The therapeutic use of new (GLP-1) obesity treatments for weight loss is a positive step towards the prevention and reduction of complications of non-communicable diseases (NCDs). We provide an intergrated weight loss health monitoring solution for individuals on GLP-1 treatment. The solution is available as either a 6 (six), 12 (twelve) or 24-months subscription.